Clinical Trial Update: Therapeutic Efficacy and Safety Evaluation of AI in the Management of Diabetes: A RCT Trial [NA]

View source ↗

Summary

A randomized controlled trial is evaluating the efficacy and safety of artificial intelligence-assisted management for type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Artificial intelligence-based diabetes management

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Diabetes Mellitus Type 2 (T2DM), Artificial Intelligence (AI) | NA | Status: RECRUITING